-
About us University College London (UCL) UCL is a multi-disciplinary university with a population of over 13,000 staff and 42,000 students from 150 different countries. Degree programmes
-
About us University College London (UCL) UCL is a multi-disciplinary university with a population of over 13,000 staff and 42,000 students from 150 different countries. Degree programmes
-
support sustainable transitions for people and planet. As a Principal Research Fellow of the Institute, the primary role will be Research Director for the UCL Centre on Net Zero Market Design, which
-
About us The UCL Institute for Global Health (IGH) is at the heart of UCL’s Grand Challenge of Global Health. The Institute’s vision is for a world where international policy on global health is
-
through the UCL–AstraZeneca Centre of Excellence, the programme will appoint six postdoctoral researchers to work across UCL and AstraZeneca sites, combining computational and experimental approaches. UCL
-
About us UCL, based in Bloomsbury, is a welcoming, inclusive university situated at the heart of one of the world’s greatest cities. UCL is a top-ranked university in the UK for research in
-
of the REFINE-MS trial, a multi-centre, phase 3 study led by Professor Olga Ciccarelli and Professor Max Parmar at UCL. The trial aims to identify the optimal dosing frequency of ocrelizumab in patients with
-
Parkinson’s Disease (EJS ACT-PD) trial is a multi-arm, multi-stage (MAMS) platform trial aiming to increase scale and pace of PD research. The trial provides a sustainable platform to efficiently assess
-
are located in Bloomsbury, at the heart of London, and offer an exciting and vibrant environment in which to study in one of the UK's top universities. The Department of Chemistry at UCL is committed
-
Clinical Trials in Parkinson’s Disease (EJS ACT-PD) trial is a multi-arm, multi-stage (MAMS) platform trial aiming to increase scale and pace of PD research. The trial provides a sustainable platform to